The company is doubling down on its vaccine success.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri®...
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524),...
Its partner's coronavirus vaccine comes one important step closer to approval in Europe.
Markets looked poised for a rebound on Tuesday.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Equity Subscription Agreement and have updated...
One of its vaccine partners had some encouraging regulatory news to report.
The company earns an Emergency Use Authorization from a well-off Middle Eastern country.
VALN earnings call for the period ending March 31, 2022.
The company and its partner Valneva had some good news to report.